NCT06032104

Brief Summary

Beans are a forgotten staple food that shows promise in improving health. The goal of this study is to look at how bean supplementation affects metabolic and bowel health. In the long-term, the investigators believe this research will lead to a better understanding of the impact of beans on bowel health. The investigators also hope that this research study will help us understand ways to improve human diet and prevent colon cancer in the future.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Oct 2023Sep 2026

First Submitted

Initial submission to the registry

August 24, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 27, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

December 5, 2025

Status Verified

December 1, 2025

Enrollment Period

2.8 years

First QC Date

August 24, 2023

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Compliance with the bean smoothie intervention

    Mean percentage completion of bean smoothie intervention and mean percentage with positive breath test over 2 weeks

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Tolerance to the bean smoothie intervention

    Compare the mean change in individual gastrointestinal symptoms and scores between paired baseline- and post- bean smoothie intervention vs. usual care. Patient-Reported Outcomes Measurement Information System (PROMIS) survey T sore range is 1-100, normal average T score is 50 (Standard deviation of 10).

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Effect of the bean smoothie intervention on serum biomarkers of health

    Compare the percent with abnormal complete metabolic panel or complete blood count between paired baseline- and post- bean smoothie intervention vs. usual care

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Change in fecal abundance of microbiome genes with bean smoothie intervention

    Fecal microbiome assessment using 16s/metagenomics assay. Investigators will compare the change in paired baseline- and post- bean smoothie intervention vs. usual diet

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Change from baseline in the fecal and serum metabolome with bean smoothie intervention

    Fecal and serum metabolomic assessment using an untargeted metabolomics assay. Investigators will compare the change in paired baseline- and post- bean smoothie intervention vs. usual diet

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Impact of bean intervention on colonic tissue RNA markers of health

    Compare colonic tissue RNA-seq assay between participants randomized to bean intervention vs usual care before the colonoscopy

    2-4 weeks prior to colonoscopy till colonoscopy

Secondary Outcomes (5)

  • Change from baseline in body composition

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Change from baseline in body mass index (BMI)

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Change from baseline in waist circumference

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Reported change from baseline in fitness level

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

  • Reported change from baseline in and exercise per week

    2-4 weeks prior to colonoscopy, till 2-12 weeks after colonoscopy

Study Arms (2)

Bean smoothie then usual diet

EXPERIMENTAL

Participants first receive 2 weeks of adding bean smoothie to usual diet before colonoscopy. After colonoscopy, they receive usual diet for 2 weeks

Dietary Supplement: Dry beansDietary Supplement: Usual diet

Usual diet then bean smoothie

EXPERIMENTAL

Participants first receive 2 weeks of usual diet before colonoscopy. After colonoscopy, they add bean smoothie to usual diet for 2 weeks

Dietary Supplement: Dry beansDietary Supplement: Usual diet

Interventions

Dry beansDIETARY_SUPPLEMENT

0.5 cup of Bush's Best Cannellini Beans, three times per day before meals blended into a smoothie. If interested and depending on tolerance, participants will also have the opportunity to gradually increase the bean smoothie to a maximum of 1 cup three times per day before meals during the last week of the two-week bean smoothie intervention. If patient cannot not tolerate 1.5 cup of canned cannellini bean, we will reduce per tolerance or offer the option of choosing a bean-based flour (100 gram/day, 23% fiber from Archer Daniels Midland)

Bean smoothie then usual dietUsual diet then bean smoothie
Usual dietDIETARY_SUPPLEMENT

Usual diet without adding the bean smoothie

Bean smoothie then usual dietUsual diet then bean smoothie

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Inclusions: 1. 30-80 years-old 2. Overweight or obesity (body mass index ≥ 25 kg/m2) 3. Planned for a standard of care colonoscopy for colon cancer screening Exclusions: 1. Intolerance to a bean or high bean consumer based on a screening survey 2. Pregnancy or actively planning to get pregnant 3. Any active gastrointestinal disease resulting in disturbed gut function or malabsorption (e.g., chronic diarrhea or inflammatory bowel disease) 4. Current or history of any malignancy in the past 10 years. 5. Chronic use of opioids, anti-inflammatory drugs, antibiotics, prebiotics, or probiotics within 1 month of study endpoints 6. History of a significant systemic condition (e.g., heart disease, chronic kidney disease, liver dysfunction or immune suppression), or abnormal laboratory markers (e.g., abnormal liver enzymes, creatinine, clotting factors, or low platelets count). The severity of the intolerance to fiber/ the medical conditions/lab markers and eligibility will be defined after the careful interview of the patient/review of the medical records by Dr. Hussan)

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University of California Davis

Sacramento, California, 95817, United States

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hisham Hussan, MD

    UC Davis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hisham Hussan, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: The randomized clinical trial has a cross-over design. The 20 participants will be randomized to a 14-day bean intervention versus usual care pre- or post-colonoscopy with a cross-over design. The 14-day bean intervention will be preceded by a 3-day ramp-up, acclimation, phase of beans feeding starting at one 1/2 cup of beans for day 1, followed by two 1/2 cups/day for days 2 and 3, then the full dose of three 1/2 cups/day for 14 days afterwards. Participants will be randomized 1:1 using a stratified randomization design. The randomization strata will be sex and presence/absence of metabolic syndrome factors with 1:1 ratio. Investigators anticipate a 20% dropout; therefore, investigators will recruit 25 participants to complete procedures on 20.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2023

First Posted

September 11, 2023

Study Start

October 27, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

December 5, 2025

Record last verified: 2025-12

Locations